1981
DOI: 10.1021/jm00144a013
|View full text |Cite
|
Sign up to set email alerts
|

(-)-4-Hydroxymorphinanones: their synthesis and analgesic activity

Abstract: A facile procedure is described for the conversion of morphine, via the diphosphate ester derivative 1 followed by catalytic reduction and treatment with Li/NH3, to 3-deoxy-7,8-dihydromorphine (3). Oxidation with benzophenone tert-butoxide converted 3 to the ketone 4, which on treatment with Zn/NH4Cl formed (-)-4-hydroxymorphinan-6-one 5. Reaction of 5 with diazomethane formed the methyl ether 6. The N-cyclopropylmethyl analogues of 4 and 5 were also prepared, i.e., 8c and 9 from 4. The antinociceptive activit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0

Year Published

1982
1982
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 6 publications
0
8
0
Order By: Relevance
“…We envisioned that with readily available inputs, an intramolecular C–H activation, alkenylation, electrocyclization, and reduction sequence could provide rapid access to fused bicyclic cores that in just a few additional steps could be taken on to diverse morphinan products. To demonstrate this approach, we reported total syntheses of the enantiomer of the semisynthetic opioid agonist (+)-ketorfanol , and the more complex opioid antagonist (−)-naltrexone, , which is widely used to treat opioid addiction.…”
Section: Asymmetric Synthesis Of (+)-Ketorfanol and (−)-Naltrexonementioning
confidence: 99%
See 1 more Smart Citation
“…We envisioned that with readily available inputs, an intramolecular C–H activation, alkenylation, electrocyclization, and reduction sequence could provide rapid access to fused bicyclic cores that in just a few additional steps could be taken on to diverse morphinan products. To demonstrate this approach, we reported total syntheses of the enantiomer of the semisynthetic opioid agonist (+)-ketorfanol , and the more complex opioid antagonist (−)-naltrexone, , which is widely used to treat opioid addiction.…”
Section: Asymmetric Synthesis Of (+)-Ketorfanol and (−)-Naltrexonementioning
confidence: 99%
“…We envisioned that with readily available inputs, an intramolecular C−H activation, alkenylation, electrocyclization, and reduction sequence could provide rapid access to fused bicyclic cores that in just a few additional steps could be taken on to diverse morphinan products. To demonstrate this approach, we reported total syntheses of the enantiomer of the semisynthetic opioid agonist (+)-ketorfanol 44,45 and the more complex opioid antagonist (−)-naltrexone, 4,46 which is widely used to treat opioid addiction. Rh(I)-catalyzed C−H activation and alkenylation of imine 42 afforded azatriene 43, which underwent in situ torquoselective 6π electrocyclization to give a single diastereomer of hexahydroisoquinoline 44 as determined by 1 H NMR analysis (Scheme 6).…”
Section: Asymmetric Synthesis Of (+)-Ketorfanolmentioning
confidence: 99%
“…Isolated from the opium poppy latex, morphine ( 1 ) and its congeners are among the oldest and most extensively studied alkaloid natural products known to date (Figure 1). [1] Given their potent neurological and immunological activity, morphine alkaloids and the unnatural semisynthetic opioids, such as ketorfanol, [2a] oxycodone, [2b] and naltrexone, [2c] have found various important therapeutic applications, including acting as pain killers or treating opioid abuse and alcohol dependence. Besides the biological importance, these compounds also exhibit very intriguing chemical structures, such as a unique poly‐bridged/fused ring system, a quaternary center, a basic tertiary amine moiety, and a 1,2,3,4‐tetrasubstituted arene, which have posted significant challenges for their preparation.…”
Section: Introductionmentioning
confidence: 99%
“…1). 1 Extensive modifications to the naturally occurring opioids have also been investigated in endeavors to increase potency and in vivo efficacy and have led to the discovery of semi-synthetic opioids such as (–)-ketorfanol ( 4 )2 and the extensively prescribed (–)-oxycodone ( 5 ) 3. However, despite the medical importance of naturally occurring and semi-synthetic opioid agonists, undesired side effects such as addictive properties and the potential for fatal overdoses are enormous societal problems.…”
Section: Introductionmentioning
confidence: 99%